When and how CBT for BED use GLP-1RAs CBT for BED, as detailed in a manual (Dalle Grave et al., 2024), integrates strategies and procedures from both CBT-E for eating disorders (Dalle Grave & Calugi, 2020
Capturing the Impact of Treatment Administration on Quality of Life Oral semaglutide and liraglutide are associated with substantially different administration methods (once-daily oral versus once-daily injectable, respectively)
Understanding GLP-1s and their role GLP-1 is a hormone released in the gut in response to eating
Monitor Progress: Keep track of your weight loss and energy levels over time to determine the injections effectiveness
Any legitimate investigation of this compound should occur within properly authorized clinical research under appropriate oversight, and readers should consult qualified professionals and applicable regulations before making any decisions.
In support of this, ICV administration of GLP-1 in rats has been shown to attenuate the fasting-induced rise in NPY/AgRP expression and decreases fasting-induced inhibition of POMC/CART expression in the ARC (Seo et al., 2008)